US Patent Issued to Boulder BioScience on Jan. 20 for "Methods of treating acute coronary syndrome using 3,3'-diindolylmethane" (Colorado, Missouri Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,766, issued on Jan. 20, was assigned to Boulder BioScience LLC (Boulder, Colo.).

"Methods of treating acute coronary syndrome using 3,3'-diindolylmethane" was invented by Michael A. Zeligs (Boulder, Colo.) and Irwin C. Jacobs (Defiance, Mo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of enhancing mechanical thrombectomy during endovascular therapy for acute thrombosis using 3,3'-diindolylmethane."

The patent was filed on April 8, 2024, under Application No. 18/629,099.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%...